The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Boursier, Jérôme, Mueller, Olaf, Barret, Matthieu, Machado, Mariana, Fizanne, Lionel, Araujo‐Perez, Felix, Guy, Cynthia D., Seed, Patrick C. +6 more·2016·Hepatology
DOI 10.1002/hep.28356

Cited by (1,000)

Items 201–300 of 1,000

  1. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFκB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice
    Xiaoqin Ding, Tunyu Jian, Jiawei Li, Han Lv, Bei Tong, Jing Li, Xiuhua Meng, Bingru Ren, Jian Chen · 2020 · Oxidative Medicine and Cellular Longevity
  2. Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma
    Harry Cheuk-Hay Lau, Xiang Zhang, Jun Yu · 2025 · Nature Reviews Gastroenterology & Hepatology
  3. Early microbes modify immune system development and metabolic homeostasis-the “restaurant” hypothesis revisited
    Nash, Michael J., Frank, Daniel N., Friedman, Jacob E. · 2017 · Frontiers in Endocrinology
  4. Maternal modifiers of the infant gut microbiota: Metabolic consequences
    Mulligan, Christopher M, Friedman, Jacob E · 2017 · Journal of Endocrinology
  5. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
    Angeliki Katsarou, Ioannis I. Moustakas, Iryna Pyrina, Peter Lembessis, Michael Koutsilieris, Antonios Chatzigeorgiou · 2020 · World Journal of Gastroenterology
  6. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
    Elke Roeb, Ali E. Canbay, Frank Tacke, Heike Bantel, Jörg Bojunga, Jan de Laffolie, Münevver Demir, Ulrike Walburga Denzer, A Geier, Wolf Peter Hofmann et al. · 2022 · Zeitschrift für Gastroenterologie
  7. The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis
    Knorr, Jana, Wree, Alexander, Tacke, Frank, Feldstein, Ariel E. · 2020 · Seminars in Liver Disease
  8. Microbial Metabolites: Critical Regulators in NAFLD
    Xin Dai, Huiqin Hou, Wanru Zhang, Tianyu Liu, Yun Li, Sinan Wang, Bangmao Wang, Hailong Cao · 2020 · Frontiers in Microbiology
  9. Endotoxins and Non-Alcoholic Fatty Liver Disease
    T. Kessoku, Takashi Kobayashi, Kento Imajo, Kosuke Tanaka, A. Yamamoto, Kota Takahashi, Yuki Kasai, Anna Ozaki, Michihiro Iwaki, Asako Nogami et al. · 2021 · Frontiers in Endocrinology
  10. Gut Microbiota and Lifestyle Interventions in NAFLD
    David Houghton, Christopher James Stewart, Christopher Paul Day, Michael I. Trenell · 2016 · International Journal of Molecular Sciences
  11. Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet
    Shusong Wu, Ruizhi Hu, Hironobu Nakano, Keyu Chen, Ming Liu, Xi He, Hongfu Zhang, Jianhua He, De‐Xing Hou · 2018 · Molecules
  12. Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease
    Florian Plaza Oñate, Célia Chamignon, Sebastian D. Burz, Nicolas Lapaque, Magali Monnoye, Catherine Philippe, Maxime Bredel, Laurent Chêne, William Farin, Jean-Michel Paillarse et al. · 2023 · International Journal of Molecular Sciences
  13. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
    Vonderlin, Joscha, Chavakis, Triantafyllos, Sieweke, Michael, Tacke, Frank · 2023 · Cellular and Molecular Gastroenterology and Hepatology
  14. Gut Microbiota and Complications of Liver Disease
    Chathur Acharya, Jasmohan Singh Bajaj · 2017 · Gastroenterology Clinics of North America
  15. Gut Dysfunction and Non-alcoholic Fatty Liver Disease
    Felix Grabherr, Christoph Grander, Maria Effenberger, Timon Erik Adolph, Herbert Tilg · 2019 · Frontiers in Endocrinology
  16. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Chencheng Xie, Dina L. Halegoua-DeMarzio · 2019 · Nutrients
  17. Profiling of tumour-associated microbiota in human hepatocellular carcinoma
    Komiyama, Seiga, Yamada, Takahiro, Takemura, Nobuyuki, Kokudo, Norihiro, Hase, Koji, Kawamura, Yuki I. · 2021 · Scientific Reports
  18. Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction
    Jingze Lu, Dan Ye, Bing‐Liang Ma · 2021 · Frontiers in Pharmacology
  19. In Vivo Tissue Distribution of Polystyrene or Mixed Polymer Microspheres and Metabolomic Analysis after Oral Exposure in Mice
    Marcus A. Garcia, Aaron S. Romero, Seth D. Merkley, Jewel L. Meyer-Hagen, Charles Forbes, Eliane El Hayek, David P. Sciezka, Rachel Templeton, Jorge González-Estrella, Yan Jin et al. · 2024 · Environmental Health Perspectives
  20. Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
    Xue, Rui, Su, Lianyong, Lai, Shengyi, Wang, Yanyan, Zhao, Derrick, Fan, Jiangao, Chen, Weidong, Hylemon, Phillip B., Zhou, Huiping · 2021 · Cells
  21. Microbial metabolites in non-alcoholic fatty liver disease
    Da Zhou, Jian‐Gao Fan · 2019 · World Journal of Gastroenterology
  22. In Vitro Antimicrobial Activity and Probiotic Potential of Bifidobacterium and Lactobacillus against Species of Clostridium
    Cinara R. A. V. Monteiro, Monique Santos do Carmo, Bruna Oliveira de Melo, Matheus Silva Alves, Camilla Itapary dos Santos, Sílvio Gomes Monteiro, Maria Rosa Quaresma Bomfim, Elizabeth Soares Fernandes, Valério Monteiro‐Neto · 2019 · Nutrients
  23. Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
    Yeojun Yun, Han-Na Kim, Eun‐Ju Lee, Seungho Ryu, Yoosoo Chang, Ho Cheol Shin, Hyung‐Lae Kim, Tae Hun Kim, Kwon Yoo, Hwi Young Kim · 2019 · PLoS ONE
  24. Shrimp disease progression increases the gut bacterial network complexity and abundances of keystone taxa
    Wenfang Dai, Zheliang Sheng, Jiong Chen, Jinbo Xiong · 2019 · Aquaculture
  25. The Commensal Microbe V eillonella as a Marker for Response to an FGF19 Analog in NASH
    Loomba, Rohit, Ling, Lei, Dinh, Duy M., DePaoli, Alex M., Lieu, Hsiao D., Harrison, Stephen A., Sanyal, Arun J. · 2021 · Hepatology
  26. Microbiota, Obesity and NAFLD
    Louis Ho Shing Lau, Sunny Hei Wong · 2018 · Advances in experimental medicine and biology
  27. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan
    Ming‐Chao Tsai, Yu-Yin Liu, Chih‐Che Lin, Chih‐Chi Wang, Yi‐Ju Wu, Chee‐Chien Yong, Kuang‐Den Chen, Seng‐Kee Chuah, Chih‐Chien Yao, Pao‐Yuan Huang et al. · 2020 · Nutrients
  28. A Current Understanding of Bile Acids in Chronic Liver Disease
    Naba Farooqui, Anshuman Elhence, S. Shalimar · 2021 · Journal of Clinical and Experimental Hepatology
  29. Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury
    Cristina Rodriguez, Bernard Taminiau, Alberto García-García, Alejandro Cueto‐Sánchez, Mercedes Robles‐Díaz, Aida Ortega‐Alonso, Flores Martín‐Reyes, Georges Daube, Judith Sanabria‐Cabrera, Miguel Jiménez Pérez et al. · 2022 · Pharmacological Research
  30. Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease
    Qichen Long, Fengming Luo, Binghui Li, Ziyang Li, Zhe Guo, Zhiyang Chen, Weimin Wu, Min Hu · 2024 · Hepatology Communications
  31. Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease
    J. Pang, Weiqi Xu, Xinrong Zhang, Grace Lai‐Hung Wong, Anthony W.H. Chan, Hoi–Yun Chan, Chi‐Hang Tse, Sally She‐Ting Shu, Paul Cheung‐Lung Choi, Henry Lik‐Yuen Chan et al. · 2017 · Alimentary Pharmacology & Therapeutics
  32. Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model
    H. Hamid, J.Y. Zhang, W.X. Li, Chunfa Liu, Meiyue Li, L.H. Zhao, Cheng Ji, Q.G. Ma · 2019 · Poultry Science
  33. Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study
    Chikara Iino, Tetsu Endo, Kenichiro Mikami, Takuma Hasegawa, Masayo Kimura, Naoya Sawada, Shigeyuki Nakaji, Shinsaku Fukuda · 2019 · Hepatology International
  34. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
    Erica Jennison, Christopher D. Byrne · 2020 · Clinical and Molecular Hepatology
  35. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
    Alix Bruneau, Jana Hundertmark, Adrien Guillot, Frank Tacke · 2021 · Frontiers in Medicine
  36. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
    Jianwen Jiang, Xinhua Chen, Zhigang Ren, Shusen Zheng · 2018 · Hepatobiliary & pancreatic diseases international
  37. Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
    Daud H. Akhtar, Umair Iqbal, Luis Miguel Vazquez‐Montesino, Brittany Burns Dennis, Aijaz Ahmed · 2019 · Journal of Clinical and Translational Hepatology
  38. Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population‐Based Study of 1,355 Adults
    Louise J. M. Alferink, Djawad Radjabzadeh, Nicole Stephanie Erler, Dina Vojinović, Carolina Medina‐Gómez, André Gerardus Uitterlinden, Robert Jacobus de Knegt, Najaf Amin, M. Arfan Ikram, Harry L.A. Janssen et al. · 2020 · Hepatology
  39. Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
    Stefano Bibbò, Gianluca Ianiro, Maria Pina Dore, Claudia Simonelli, Estelle E. Newton, Giovanni Cammarota · 2018 · Mediators of Inflammation
  40. Gut microbiota, fatty liver disease, and hepatocellular carcinoma
    Chu, Huikuan, Williams, Brandon, Schnabl, Bernd · 2018 · Liver Research
  41. The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
    Orsolya Inczefi, Péter Bacsúr, Tamás Resál, Csilla Keresztes, Tamás Molnár · 2022 · Frontiers in Nutrition
  42. Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
    Takashi Kobayashi, Michihiro Iwaki, Atsushi Nakajima, Asako Nogami, Masato Yoneda · 2022 · International Journal of Molecular Sciences
  43. Sphingolipid metabolism in non-alcoholic fatty liver diseases
    Marion Régnier, Arnaud Polizzi, Hervé Guillou, Nicolas Loiseau · 2018 · Biochimie
  44. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications
    Saumya Jayakumar, Rohit Seth Loomba · 2019 · Alimentary Pharmacology & Therapeutics
  45. Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota
    Sena Bluemel, Brandon Williams, Rob D. Knight, Bernd Schnabl · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  46. Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity
    Yu‐Cheng Lin, Hsueh-Fang Lin, Chi-Chien Wu, Chun‐Liang Chen, Yen‐Hsuan Ni · 2022 · Journal of Gastroenterology
  47. The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais
    Abhasnee Sobhonslidsuk, Suwannee Chanprasertyothin, Tanjitti Pongrujikorn, Piyaporn Kaewduang, Kwannapa Promson, Supanna Petraksa, Boonsong Ongphiphadhanakul · 2018 · BioMed Research International
  48. Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH).
    S. M. Duarte, J. Stefano, C. Oliveira · 2019 · Annals of Hepatology
  49. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
    Chang‐Kee Hyun · 2021 · International Journal of Molecular Sciences
  50. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?
    Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen · 2019 · Nutrients
  51. Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice
    Nobuhiro Nakamoto, T Amiya, Ryo Aoki, Nobuhito Taniki, Yuzo Koda, Kentaro Miyamoto, Toshiaki Teratani, Takahiro Suzuki, Sayako Chiba, Po–Sung Chu et al. · 2017 · Cell Reports
  52. Uridine attenuates obesity, ameliorates hepatic lipid accumulation and modifies the gut microbiota composition in mice fed with a high-fat diet
    Yilin Liu, Chunyan Xie, Zhenya Zhai, Zeyuan Deng, Hugo R. de Jonge, Xin Wu, Zheng Ruan · 2021 · Food & Function
  53. Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease
    Huma Saeed, Luis Antonio Díaz, Antonio Gil‐Gómez, Jeremy P. Burton, Jasmohan Singh Bajaj, Manuel Romero‐Gómez, Marco A. Arrese, Juan Pablo Arab, Mohammad Qasim Khan · 2024 · Clinical and Molecular Hepatology
  54. PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date
    Cherubini, Alessandro, Casirati, Elia, Tomasi, Melissa, Valenti, Luca · 2021 · Expert Opinion on Therapeutic Targets
  55. Diet-Induced Modification of the Sperm Epigenome Programs Metabolism and Behavior
    Carina Bodden, Anthony John Hannan, Amy Claire Reichelt · 2019 · Trends in Endocrinology and Metabolism
  56. Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease
    Michelle T. Long, Sanil Gandhi, Rohit Seth Loomba · 2020 · Metabolism
  57. Chronic Liver Diseases and the Microbiome—Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
    Chathur Acharya, Jasmohan Singh Bajaj · 2020 · Gastroenterology
  58. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review
    Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, Fateme Vazife, Leonardo Antonio Sechi, Amir Hashem Shahidi Bonjar, Parnian Kord Jamshidi, Mohammad Javad Nasiri, Mehdi Seyed Mirsaeidi · 2022 · Frontiers in Cellular and Infection Microbiology
  59. Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism
    Jianjun Liu, Jiayi Sun, Jiangkun Yu, Hang Chen, Dan Zhang, Tao Zhang, Yicheng Ma, Cheng‐Gang Zou, Zhigang Zhang, Lanqing Ma et al. · 2023 · npj Biofilms and Microbiomes
  60. Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review
    Hongcai Li, Jingjing Liang, Mengzhen Han, Zhenpeng Gao · 2024 · Journal of Advanced Research
  61. A high-fat diet and high-fat and high-cholesterol diet may affect glucose and lipid metabolism differentially through gut microbiota in mice
    Huijing Liang, Fengling Jiang, Ruyue Cheng, Yating Luo, Jiani Wang, Zihao Luo, Ming Li, Xi Ping Shen, Fang He · 2020 · EXPERIMENTAL ANIMALS
  62. Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis
    Müjdat Zeybel, Muhammad Arif, Xiangyü Li, Özlem Altay, Hong Yang, Mengnan Shi, Murat Akyıldız, Burçin Sağlam, Mehmet Gökhan Gönenli, Buket Yiğit et al. · 2022 · Advanced Science
  63. Gut microbiome in gastrointestinal cancer: a friend or foe?
    Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, Xi jie Gu, Jun Zhang, Daichi Nomoto, Kazuo Okadome, Hideo Baba, Peng Qiu · 2022 · International Journal of Biological Sciences
  64. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague–Dawley Rats
    Raghdaa Al Zarzour, Mariam Ahmad, Mohd Zaini Asmawi, Gurjeet Kaur, Mohammed Ali Ahmed Saeed, Majed Ahmed Al‐Mansoub, Sultan Ayesh Mohammed Saghir, Nasiba Salisu Usman, Dhamraa W. Al-Dulaimi, Mun Fei Yam · 2017 · Nutrients
  65. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
    Monika Augustyn, Iwon Grys, Michał Kukla · 2019 · Clinical and Experimental Hepatology
  66. Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
    Xiaofan Jiang, Juan Zheng, Shixiu Zhang, Baozhen Wang, Chaodong Wu, Xin Guo · 2020 · Frontiers in Medicine
  67. Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis
    Noriho Iida, Eishiro Mizukoshi, Tatsuya Yamashita, Masahiro Yutani, Jun Seishima, Ziyu Wang, Kuniaki Arai, Hikari Okada, Taro Yamashita, Yoshio Sakai et al. · 2021 · Nature Cancer
  68. Immunoglobulin A and liver diseases
    Inamine, Tatsuo, Schnabl, Bernd · 2018 · Journal of Gastroenterology
  69. Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children
    Anika Nier, Anna Janina Engstler, Ina Barbara Maier, Ina Bergheim · 2017 · PLoS ONE
  70. Association between the Gut Microbiota and Obesity
    Kiril Mitev, Vaso Taleski · 2019 · Open Access Macedonian Journal of Medical Sciences
  71. Vitamin D receptor promotes healthy microbial metabolites and microbiome
    Ishita Chatterjee, Rong Lu, Yongguo Zhang, Jilei Zhang, Yang David Dai, Yinglin Xia, Jun Sun · 2020 · Scientific Reports
  72. Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies
    Joanna K. Hodges, Geoffrey Y. Sasaki, Richard S. Bruno · 2020 · The Journal of Nutritional Biochemistry
  73. Intestinal virome and therapeutic potential of bacteriophages in liver disease
    Cynthia L. Hsu, Yi Duan, Derrick E. Fouts, Bernd Schnabl · 2021 · Journal of Hepatology
  74. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
    Li-Ran Zhu, Shanshan Li, Wan-Qun Zheng, Wei‐Jian Ni, Ming Cai, Haipeng Liu · 2023 · Frontiers in Immunology
  75. The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease
    Dandan Cheng, Cong He, Hong-hui Ai, Ying Huang, Nonghua Lü · 2017 · Frontiers in Microbiology
  76. Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
    Francesca Fianchi, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Luca Miele · 2021 · International Journal of Molecular Sciences
  77. Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD
    Kun Xie, Xi He, Keyu Chen, Kozue Sakao, De‐Xing Hou · 2020 · Food & Function
  78. The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
    Yulin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, Xiaojing Song, Lei Zhang · 2022 · Frontiers in Cellular and Infection Microbiology
  79. Gut microbiota mediated T cells regulation and autoimmune diseases
    Nabeel Khalid Bhutta, Xiujin Xu, Cuiqin Jian, Yifan Wang, Yi Liu, Jinlyu Sun, Bingnan Han, Shandong Wu, Ansar Javeed · 2024 · Frontiers in Microbiology
  80. Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency
    Limin Liu, Qingsong Fu, Tiantian Li, Kai Shao, Xing Zhu, Yingzi Cong, Xiaoyun Zhao · 2022 · PLoS ONE
  81. Faeces‐derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases
    Lionel Fizanne, Alexandre Villard, Nadia Benabbou, Sylvain Recoquillon, Raffaella Soleti, Erwan Delage, Mireille Wertheimer, Xavier Vidal‐Gómez, Thibauld Oullier, Samuel Chaffron et al. · 2023 · Journal of Extracellular Vesicles
  82. Gut microbiota in non‐alcoholic fatty liver disease and alcohol‐related liver disease: Current concepts and perspectives
    Juan Pablo Arab, Marco A. Arrese, Vijay H. Shah · 2019 · Hepatology Research
  83. A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD
    Tien Sy Dong, William R. Katzka, Venu Lagishetty, Kayti Luu, Meg Hauer, Joseph R. Pisegna, Jonathan P. Jacobs · 2020 · Scientific Reports
  84. Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
    Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri · 2022 · Biology
  85. Resynchronized rhythmic oscillations of gut microbiota drive time-restricted feeding induced nonalcoholic steatohepatitis alleviation
    Jiafeng Xia, Wanru Guo, Ming Hu, Xiuyuan Jin, Sitong Zhang, Boqiang Liu, Hangyuan Qiu, Kaicen Wang, Aoxiang Zhuge, Shengjie Li et al. · 2023 · Gut Microbes
  86. The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
    Giuseppe Losurdo, Fulvio Salvatore D’Abramo, Giuseppe Indellicati, Chiara Lillo, Enzo Ierardi, Alfredo Di Leo · 2020 · International Journal of Molecular Sciences
  87. Multi-omics profiling: the way toward precision medicine in metabolic diseases
    Cheng Hu, Weiping Jia · 2021 · Journal of Molecular Cell Biology
  88. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
    Piero Portincasa, Mohamad Khalil, Annarita Graziani, Gema Frühbeck, György Baffy, Gabriella Garruti, Agostino Di Ciaula, Leonilde Bonfrate · 2023 · European Journal of Internal Medicine
  89. Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations
    Jacopo Troisi, Luca Pierri, Annamaria Landolfi, Francesca Marciano, A. Bisogno, Federica Belmonte, Carmen Palladino, Salvatore Guercio Nuzio, Pietro Campiglia, Pietro Vajro · 2017 · Nutrients
  90. Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats
    Yingyue Tang, Jingyi Zhang, Jing Li, Xiaohong Lei, Dongke Xu, Yang Wang, Chunmin Li, Xiaobo Li, Yimin Mao · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  91. Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Sebastian D. Burz, Magali Monnoye, Catherine Philippe, William Farin, Vlad Ratziu, Francesco Strozzi, Jean-Michel Paillarse, Laurent Chêne, Hervé M. Blottière, Philippe Gérard · 2021 · Microorganisms
  92. Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease
    Xiongfeng Pan, Atipatsa Chiwanda Kaminga, Aizhong Liu, Shi Wu Wen, Miyang Luo, Jiayou Luo · 2021 · Frontiers in Cellular and Infection Microbiology
  93. The Gut–Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases
    Natalia Di Tommaso, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani · 2023 · International Journal of Molecular Sciences
  94. Combined alcoholic and non-alcoholic steatohepatitis
    Line Carolle Ntandja Wandji, Viviane Gnemmi, Philippe Mathurin, Alexandre Louvet · 2020 · JHEP Reports
  95. Gut Microbiota and Chemical-Induced Acute Liver Injury
    Tao Chen, Rui Li, Peng Chen · 2021 · Frontiers in Physiology
  96. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
    Manfredi Rizzo, Alessandro Colletti, Peter Edward Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter Paul Toth, Ioanna Gouni‐Berthold, John Mancini, DAVID P. MARAIS, Patrick M. Moriarty et al. · 2023 · Pharmacological Research
  97. Role of intestinal probiotics in the modulation of lipid metabolism: implications for therapeutic treatments
    Xiaoran Song, Yanan Liu, Xin Zhang, Peifang Weng, Ruilin Zhang, Zufang Wu · 2023 · Food Science and Human Wellness
  98. Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders
    Emiliano Peña-Durán, Jesús Jonathan García-Galindo, Luis Daniel López-Murillo, Alfredo Huerta-Huerta, Luis Ricardo Balleza-Alejandri, Alberto Beltrán-Ramírez, Elsa Janneth Anaya-Ambriz, Daniel Osmar Suárez-Rico · 2025 · International Journal of Molecular Sciences
  99. Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease
    Yulang Chi, Yi Lin, Yan-Yang Lu, Qiansheng Huang, Guozhu Ye, Sijun Dong · 2018 · The Science of The Total Environment
  100. Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH
    Adriana Carino, Michele Biagioli, Silvia Marchianò, Chiara Fiorucci, Angela Zampella, Maria Chiara Monti, Paolo Tommaso Scarpelli, Patrizia Ricci, Eleonora Distrutti, Stefano Fiorucci · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids